Caring Causes: Wines for a Worthy Cause

Toast the holidays with a wine that gives back. By purchasing Jarman Wines you will not only enjoy certified organic ultra premium wines, but you will be supporting a worthy cause, finding a cure for Alzheimer's disease.

Jarman Wines make the perfect hostess gifts and party offerings. Even better, each purchase will help to benefit the Alzheimer's Drug Discovery Foundation (ADDF). In addition, the winery has opened a tasting lounge in Carmel Valley that offers three levels of wine tasting and three specially themed picnic packages. Gift certificates for the picnic packages make the perfect holiday gift.

To honor her late mother's memory, Holman Ranch CEO and eldest daughter Hunter Lowder took the best hand-selected estate grapes and created two premium varietals—Jarman Chardonnay and Jarman Pinot Noir—with $1 from each bottle sold going to the ADDF.

Jarman Lowder, Hunter’s mother, grew up in Chattanooga, Tenn., and lived up to being voted “best all around” in high school. She earned a nursing degree, worked as an R.N. and raised three daughters with her husband, Thomas. An active volunteer, animal lover, athlete and enthusiastic traveler, Jarman wanted to spend her golden years making wine with her husband at Holman Ranch, an idyllic piece of property in Carmel Valley, Ca. they purchased to realize that dream. Tragically, Lowder died in March 2011 at age 60 following a long battle with early-onset Alzheimer's disease.

Holman Ranch and Jarman Wines have partnered with the ADDF to support research toward treatment and a cure for Alzheimer’s disease and to celebrate the life of Jarman Lowder.

Give the Gift of a Wine Society Membership:

Enjoy the prestige of being a part of an exclusive membership! Receiving shipments of limited-production Jarman Estate Pinot Noir and Jarman Estate Chardonnay is an excellent way to build a cellar through two special installments of Jarman vintages, Heritage Society and Legacy Society. Email info@jarmanwine.com for more information on the exclusive benefits. Membership is limited to 150 members due to the very limited case production.  For more information on benefits visit the website here.

About Jarman Wines:

Jarman’s terroir (a French word that speaks to a wine’s place of origin, its subtle nuances of traceable character, flavor, lineage and integrity) refers to a special place in Carmel Valley — and also to a special woman, family matriarch Jarman Fearing Lowder, who inspired a family to bottle the essence of a mother’s spirit.

A Jarman wine reflects quality, with only the best local grapes used during an artisanal, small-batch winemaking process. 

 - Newest offerings from the Jarman estate include; 2014 Estate Chardonnay, 2014 Estate Pinot Noir, and 2013 Estate Pinot Noir.

Jarman wine uses only 100-percent estate-grown, certified organic and certified sustainable grapes. Aged in French oak barrels, Jarman’s vintages are held in limited supply, and are not available anywhere outside their tasting room in Carmel Valley Village (open noon to 5 p.m., Thurs.-Sun.; or by appointment), next to the historical Will’s Fargo Restaurant & Bar, the restaurant the family purchased in 2014.

The tastings will feature full-fledged experiences, including tours and wine education, and each culinary parings that complements the wine. The new Jarman Tasting Lounge & Patio provides visitors with four unique experiences: Vin de Table, Cru Tasting, Premier Cru Experience and the Grand Cru Experience.

For more information call Jarman Tasting Lounge & Patio at 831-298-7300 or email info@jarmanwine.com.

About the ADDF:

Founded in 1998 by co-chairmen Leonard A. and Ronald S. Lauder, the Alzheimer’s Drug Discovery Foundation is dedicated to rapidly accelerating the discovery of drugs to prevent, treat and cure Alzheimer's disease. It follows a venture philanthropy model, funding promising research in academia and the biotech industry. It’s the only such charity solely dedicated to funding the development of drugs for Alzheimer’s. Since its founding, the ADDF has awarded more than $75 million to fund over 450 Alzheimer’s drug discovery programs and clinical trials in 18 countries. By supporting innovative research projects around the globe, the ADDF increases the chance of finding a cure.